This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Kaufman, Michael
Item Type | Name |
Concept
|
Receptor, Platelet-Derived Growth Factor alpha
|
Concept
|
Receptor, Platelet-Derived Growth Factor beta
|
Concept
|
Vascular Endothelial Growth Factor Receptor-2
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
Concept
|
Receptor, Macrophage Colony-Stimulating Factor
|
Concept
|
Receptor, TIE-2
|
Concept
|
DCC Receptor
|
Academic Article
|
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants.
|
Academic Article
|
Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT).
|
Academic Article
|
Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase.
|
Academic Article
|
Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2.
|
Academic Article
|
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors.
|
Academic Article
|
Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors.
|
- Receptor
- Platelet Derived Growth Factor
- alpha